Olaf Weingart

2.1k total citations
20 papers, 781 citations indexed

About

Olaf Weingart is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Olaf Weingart has authored 20 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Public Health, Environmental and Occupational Health and 3 papers in Genetics. Recurrent topics in Olaf Weingart's work include Erythropoietin and Anemia Treatment (8 papers), Clinical practice guidelines implementation (7 papers) and Medical and Health Sciences Research (4 papers). Olaf Weingart is often cited by papers focused on Erythropoietin and Anemia Treatment (8 papers), Clinical practice guidelines implementation (7 papers) and Medical and Health Sciences Research (4 papers). Olaf Weingart collaborates with scholars based in Germany, United Kingdom and United States. Olaf Weingart's co-authors include Julia Bohlius, Andreas Engert, Jerome Seidenfeld, Guido Schwarzer, Sven Trelle, Chris Hyde, Margaret Piper, Susan Bayliss, Jayne S. Wilson and Josie Sandercock and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cochrane Database of Systematic Reviews.

In The Last Decade

Olaf Weingart

20 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Weingart Germany 7 554 159 156 152 92 20 781
Paula F. Ypma Netherlands 15 464 0.8× 100 0.6× 140 0.9× 54 0.4× 121 1.3× 57 770
Jonas Wallvik Sweden 17 445 0.8× 57 0.4× 215 1.4× 187 1.2× 51 0.6× 32 871
David H. Regan United States 7 774 1.4× 252 1.6× 263 1.7× 196 1.3× 23 0.3× 9 991
Jan Foubert Belgium 7 435 0.8× 263 1.7× 138 0.9× 112 0.7× 14 0.2× 14 790
Robert Card Canada 16 386 0.7× 29 0.2× 170 1.1× 139 0.9× 13 0.1× 46 805
Claudia Beghé United States 9 197 0.4× 160 1.0× 101 0.6× 29 0.2× 8 0.1× 18 650
Rita Santoro Italy 17 500 0.9× 77 0.5× 137 0.9× 11 0.1× 159 1.7× 86 1.0k
Simona Maria Siboni Italy 17 568 1.0× 23 0.1× 153 1.0× 26 0.2× 52 0.6× 55 839
Bindu Kanapuru United States 14 177 0.3× 306 1.9× 71 0.5× 12 0.1× 39 0.4× 40 767
F Hanberg-Sørensen Denmark 8 158 0.3× 221 1.4× 35 0.2× 325 2.1× 10 0.1× 9 863

Countries citing papers authored by Olaf Weingart

Since Specialization
Citations

This map shows the geographic impact of Olaf Weingart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Weingart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Weingart more than expected).

Fields of papers citing papers by Olaf Weingart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Weingart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Weingart. The network helps show where Olaf Weingart may publish in the future.

Co-authorship network of co-authors of Olaf Weingart

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Weingart. A scholar is included among the top collaborators of Olaf Weingart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Weingart. Olaf Weingart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langer, Gero, Dagmar Lühmann, Anke Steckelberg, et al.. (2013). Eckpunktepapier zur Weiterentwicklung des „Curriculums Evidenzbasierte Medizin“ der Bundesärztekammer und dem Deutschen Netzwerk Evidenzbasierte Medizin e.V.. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 107(1). 70–73. 1 indexed citations
2.
Tonia, Thomy, Annette Mettler, Nadège Robert, et al.. (2012). Erythropoietin or darbepoetin for patients with cancer. Cochrane Database of Systematic Reviews. 2012(12). CD003407–CD003407. 194 indexed citations
3.
4.
Skoetz, Nicole, Olaf Weingart, Ina Monsef, et al.. (2009). Ninth Biannual Report of the Cochrane Haematological Malignancies Group--Focus on Hematopoietic Growth Factors. JNCI Journal of the National Cancer Institute. 101(9). E1–E1. 1 indexed citations
5.
Blank, Wolfgang & Olaf Weingart. (2009). EbM von unten: Sind Fragen nach Evidenz zu klinischen Alltagsproblemen beantwortbar?. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 103(7). 425–430. 2 indexed citations
6.
7.
8.
Bohlius, Julia, Corinne Brillant, Mike Clarke, et al.. (2008). Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group. Blood. 112(11). 4675–4675. 4 indexed citations
9.
Weingart, Olaf, et al.. (2007). Sixth Biannual Report of the Cochrane Haematological Malignancies Group Focus on Non-Hodgkin Lymphoma. JNCI Journal of the National Cancer Institute. 99(17). E1–E1. 3 indexed citations
10.
Weingart, Olaf, et al.. (2006). Fifth Biannual Report of the Cochrane Haematologic Malignancies Group—Focus on Multiple Myeloma. JNCI Journal of the National Cancer Institute. 98(16). E2–E2. 2 indexed citations
11.
Bohlius, Julia, Jayne S. Wilson, Jerome Seidenfeld, et al.. (2006). Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients. JNCI Journal of the National Cancer Institute. 98(10). 708–714. 392 indexed citations
12.
Seidenfeld, Jerome, Margaret Piper, Julia Bohlius, et al.. (2006). Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment. Europe PMC (PubMed Central). 42 indexed citations
13.
Bohlius, Julia, Olaf Weingart, Sven Trelle, & Andreas Engert. (2006). Cancer-related anemia and recombinant human erythropoietin—an updated overview. Nature Clinical Practice Oncology. 3(3). 152–164. 81 indexed citations
14.
Weingart, Olaf, Nicole Skoetz, Britta Lang, Bernd Richter, & Andreas Engert. (2005). [Patient participation in the Cochrane Collaboration--barriers, experience, and concepts in Germany].. PubMed. 99(6). 367–71. 1 indexed citations
15.
Skoetz, Nicole, Olaf Weingart, & Andreas Engert. (2005). A consumer network for haematological malignancies. Health Expectations. 8(1). 86–90. 5 indexed citations
16.
Bohlius, Julia, Jayne S. Wilson, Susan Bayliss, et al.. (2005). Epoetin and Darbepoetin To Treat Cancer Patients: Updated Meta-Analysis Results.. Blood. 106(11). 751–751. 4 indexed citations
17.
Weingart, Olaf, R. G. H. Baumeister, Klaus Giersiepen, et al.. (2004). [The German Guideline Clearinghouse on Breast Cancer: the need for frequent updating of breast cancer guidelines requires effective guideline updating procedures].. PubMed. 98(5). 403–11. 1 indexed citations
18.
Thöle, H., Olaf Weingart, Ulrike Lampert, et al.. (2003). Das Leitlinien-Clearingverfahren Asthma bronchiale - 1. Methodik und Ergebnisse der formalen Bewertung. Pneumologie. 57(8). 459–467. 5 indexed citations
19.
Ollenschläger, G., et al.. (2002). Aktuelle Initiativen zur Realisierung nationaler Leitlinien in Deutschland - eine Übersicht. Das Gesundheitswesen. 64(10). 513–520. 4 indexed citations
20.
Dettmers, C., et al.. (1993). CO2 reactivity in the ischaemic core, penumbra, and normal tissue 6 hours after acute MCA-occlusion in primates. Acta Neurochirurgica. 125(1-4). 150–155. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula F. Ypma Breakdown of academic impact, for papers by Jonas Wallvik Breakdown of academic impact, for papers by David H. Regan Breakdown of academic impact, for papers by Jan Foubert Breakdown of academic impact, for papers by Robert Card Breakdown of academic impact, for papers by Claudia Beghé Breakdown of academic impact, for papers by Rita Santoro Breakdown of academic impact, for papers by Simona Maria Siboni Breakdown of academic impact, for papers by Bindu Kanapuru Breakdown of academic impact, for papers by F Hanberg-Sørensen
Rankless by CCL
2026